Yutaka Shima

TitlePostdoctoral Scholar
InstitutionUniversity of California San Diego
Address9500 Gilman Drive #0695
La Jolla CA 92093
vCardDownload vCard

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
    List All   |   Timeline
    1. Ogawara Y, Katsumoto T, Aikawa Y, Shima Y, Kagiyama Y, Soga T, Matsunaga H, Seki T, Araki K, Kitabayashi I. IDH2 and NPM1 Mutations Cooperate to Activate Hoxa9/Meis1 and Hypoxia Pathways in Acute Myeloid Leukemia. Cancer Res. 2015 May 15; 75(10):2005-16. PMID: 25795706.
      View in: PubMed
    2. Aikawa Y, Yamagata K, Katsumoto T, Shima Y, Shino M, Stanley ER, Cleary ML, Akashi K, Tenen DG, Kitabayashi I. Essential role of PU.1 in maintenance of mixed lineage leukemia-associated leukemic stem cells. Cancer Sci. 2015 Mar; 106(3):227-36. PMID: 25529853; PMCID: PMC4373983.
    3. Shima Y, Honma Y, Kitabayashi I. PML-RARa and its phosphorylation regulate pml oligomerization and HIPK2 stability. Cancer Res. 2013 Jul 15; 73(14):4278-88. PMID: 23722549.
      View in: PubMed
    4. Shima Y, Kitabayashi I. Deregulated transcription factors in leukemia. Int J Hematol. 2011 Aug; 94(2):134-141. PMID: 21823042.
      View in: PubMed
    5. Shima Y, Suzuki T, Kubo K. [An 18-year-old male developing fever, coughing and respiratory insufficiency after smoking]. Nihon Naika Gakkai Zasshi. 2010 Jan 10; 99(1):177-8, 193-4. PMID: 20376963.
      View in: PubMed
    6. Shima Y, Shima T, Chiba T, Irimura T, Pandolfi PP, Kitabayashi I. PML activates transcription by protecting HIPK2 and p300 from SCFFbx3-mediated degradation. Mol Cell Biol. 2008 Dec; 28(23):7126-38. PMID: 18809579; PMCID: PMC2593379.
    7. Ohno O, Shima Y, Ikeda Y, Sakurai K, Watanabe K, Kawai Y, Umezawa K. Inhibition of cellular adhesion in human umbilical vein endothelial cells by NF-kappaB inhibitor DHMEQ under flow. Oncol Res. 2005; 15(4):189-97. PMID: 17822279.
      View in: PubMed
    8. Kikuchi E, Horiguchi Y, Nakashima J, Kuroda K, Oya M, Ohigashi T, Takahashi N, Shima Y, Umezawa K, Murai M. Suppression of hormone-refractory prostate cancer by a novel nuclear factor kappaB inhibitor in nude mice. Cancer Res. 2003 Jan 01; 63(1):107-10. PMID: 12517785.
      View in: PubMed